Emsita-D 50/10 Tablet contains Dapagliflozin and Sitagliptin, a combination used to help control blood glucose levels in individuals with diabetes. Dapagliflozin works by reducing the reabsorption of glucose in the kidneys so that excess sugar can be removed from the body through urine. Sitagliptin works by increasing the activity of incretin hormones that stimulate insulin release and reduce glucose production after meals. Together these medicines help maintain better glycemic control and support stable blood sugar levels throughout the day. Proper blood glucose management is important for preventing long term complications associated with diabetes. The medicine is usually taken according to the dosage prescribed by a healthcare professional. Lifestyle measures such as balanced nutrition, regular exercise, and weight management can further support treatment effectiveness. When used under proper medical guidance, Emsita-D 50/10 Tablet helps support effective blood sugar control and metabolic health.